UPDATE : Wednesday, August 12, 2020
상단여백
Survey paints gloomy outlook for Korea’s developing Covid-19 treatment
About 60 percent of workers in the domestic pharmaceutical industry predict...
by Shim Hyun-tai  |  2020-06-12 17:56
라인
PharmAbcine inks CDMO deal with Australian firm for immunotherapy candidate
PharmAbcine, an antibody new drug developer, has signed a CDMO (contract de...
by Lee Han-soo  |  2020-06-12 17:15
라인
Regulators OKs Pharmicell’s P2 trial of erectile dysfunction treatment
Pharmicell said that the Ministry of Food and Drug Safety has approved its ...
by Lee Han-soo  |  2020-06-12 16:07
라인
Takeda’s sell-off of primary care biz to Celltrion triggers union protest
Celltrion said that it has acquired the business rights for 18 brands of Ta...
by Lee Han-soo  |  2020-06-12 15:32
라인
GC LabCell releases clinical results of NK cell therapy
GC LabCell has unveiled the study data of the combined therapy of its natur...
by Shim Hyun-tai  |  2020-06-11 17:34
라인
Genexine to start P1 trial of Covid-19 treatment in US
Genexine said NeoImmuneTech, its U.S. affiliate, has received approval from...
by Lee Han-soo  |  2020-06-11 16:26
라인
MSD Korea’s trade union refuses to use controversial monitoring program
The labor union of MSD Korea went up and arms about the company’s enhanced ...
by Kim Yun-mi  |  2020-06-11 14:31
라인
'Imfinzi changed treatment paradigm for non-resectable NSCLC'
Clinical results have shown that AstraZeneca's Imfinzi may be an effect...
by Lee Han-soo  |  2020-06-10 17:58
라인
‘Abbvie’s psoriasis drug proves long-term treatment effect’
Abbvie's Skyrizi (ingredient: risankizumab) showed the best treatment e...
by Shim Hyun-tai  |  2020-06-10 15:59
라인
Baekje to distribute Leo Pharma's dermatology products
Baekje Pharmaceutical said that it would exclusively distribute all of Leo ...
by Lee Han-soo  |  2020-06-09 16:49
라인
LegoChem licenses in Covid-19 treatment candidates
LegoChem BioScience licensed in two Covid-19 treatment candidates from the ...
by Lee Han-soo  |  2020-06-09 16:48
라인
MSD Korea’s privacy breach controversy resurfaces
MSD Korea’s “Self-Assurance Program (SAP),” recording conversations of doct...
by Kim Yun-mi  |  2020-06-09 11:26
라인
Korean, US firms in legal battle over Covid-19 vaccine know-how
A legal dispute is underway between American vaccine maker Inovio and VGXI,...
by Lee Han-soo  |  2020-06-08 21:28
라인
Drug sales reps move briskly amid worries over Covid-19 resurge
Visits by pharmaceutical sales representatives to doctors have begun to reb...
by Kim Yun-mi  |  2020-06-08 15:52
라인
Kainos nears end of HIV drug’s clinical trials in China
Kainos Medicine said Friday it has completed the administration of a human ...
by Shim Hyun-tai  |  2020-06-05 17:40
라인
Rinvoq joins competition among JAK inhibitors
AbbVie Korea has obtained approval for rheumatoid arthritis treatment Rinvo...
by Kim Yun-mi  |  2020-06-05 16:16
라인
IVI ties up with SNUH for clinical trial of Covid-19 vaccine
The International Vaccine Institute (IVI) and Seoul National University Hos...
by Lee Han-soo  |  2020-06-04 17:04
라인
Huons’ dry eye drop scores German nod for clinical trial
Huons said Thursday that the German Federal Institute for Drugs and Medical...
by Shim Hyun-tai  |  2020-06-04 16:25
라인
MedPacto to test Vactosertib for treating NSCLC
MedPacto has applied for phase 2 clinical trials concerning the combined us...
by Lee Han-soo  |  2020-06-04 12:43
라인
Dupixent to provide new treatment options for asthma patients
Sanofi-Aventis Korea said Wednesday it would enter the local asthma drug ma...
by Lee Han-soo  |  2020-06-03 17:54
여백
여백
여백
Back to Top